RecruitingNCT06915584

Drug Management in Heart Failure


Sponsor

IRCCS San Raffaele Roma

Enrollment

450 participants

Start Date

Nov 30, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Aim of the proposal is to create an interactive AI-based multicentre prospective database to provide information on how to improve the QoC for pts with HF.This will provide detailed information on pts characteristics,treatment practices, adherence to prescribed guideline-based optimal drug therapy,and outcomes.The database stems from a registry started two years ago,conceived to provide a contemporary snapshot on the adherence to the latest European GGLL for the therapeutic management of pts with HF.The database will be integrated with a specifically designed algorithm that provides an accurate feedback on whether patients are properly treated according to the ESC most recent recommendations.The expected outcomes are:-define non-adherence level to GGLL-based recommendations for treatment of HF;-provide information on initiation, adherence and persistence over time of the recommended treatment;-reduce medical inertia;produce practical implications to reduce morbidity and mortality


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at how heart failure medications are managed and adjusted in patients who are currently hospitalized or recently hospitalized due to a worsening of their heart failure. The goal is to improve medication management strategies. **You may be eligible if...** - You are over 18 years of age (any gender) - You have been diagnosed with heart failure for more than 6 months - You are currently in the hospital or have recently been admitted for a heart failure flare-up - You have signed informed consent **You may NOT be eligible if...** - You have been diagnosed with cancer - You have severe COPD (a lung condition with very low lung function) - You have severe valve disease that requires heart surgery - Your doctor believes participation could be unsafe for you Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

IRCCs San Raffaele

Rome, RM, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06915584


Related Trials